Newsroom | The Exchange Welcomes

Corin Group plc

We are pleased to welcome Corin Group plc to techMARK mediscience. Corin Group designs and manufactures a range of innovative orthopaedic devices that are sold worldwide.

Corin Group's principal product focus is on joint replacement for the treatment of degenerative arthritis. Within this sector it has developed several proprietary products for the young active arthritic. Its key product areas are: joint replacement (Corin Medical), trauma and sports injuries (Corifix), spinal surgery systems (Corin spinal systems) and orthopaedic theatre disposals (Corin care). Additionally, Corin Group's activities conform to a comprehensive, 3 level quality system which has achieved certification to ISO 9001 and EN4600 quality standards.

Corin Group operates a network of over 100 distributors and associate companies through which its teams of orthopaedic professionals provide consultancy and support to surgeons and theatre staff worldwide.

Corin Group believes that its flotation will help to raise its profile, attract skilled employees and enable it to access a wider range of investor.

Placing Statistics:

Placing price - 111p
Market capitalisation at placing price - 39m
Net proceeds of the placing receivable by the company - 20.6m